Reported cases of meningococcal disease in the United States are at historically low levels. Although introduction of meningococcal conjugate vaccine in 2005 appears to have contributed to this decline, no clear explanation is available to account for the decline in disease for the 10 years prior to widespread vaccine use. Furthermore, disease attributable to serogroup B has declined in the past 15 years, and no commercially available meningococcal vaccine in the United States includes this serogroup.

Which of the following statements regarding meningococcal disease is false?

Lancet. 2007;369:2196

Complications of meningococcemia: A. purpura; B. intraocular hemorrhage; C. gangrene of the fingers; D. hemorrhagic adrenals

Answer: e is not correct. Routine vaccination is not recommended for children 2 months through 10 years of age. Exceptions include children in this age group at increased risk of meningococcal disease because of persistent complement component deficiencies and children with functional or anatomic asplenia. Young...

You do not currently have access to this content.